Last reviewed · How we verify
NCT03643302
Airway Clearance and Bronchoalveolar Lavage for Bronchiectasis Patients With Exacerbation
trial testing Version BF-1T26 electronic bronchoscope in Bronchiectasis Adult in 189 participants. Completed in 18 March 2019.
28 February 2019
Quick facts
| Lead sponsor | Shanghai Pulmonary Hospital, Shanghai, China |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 189 |
| Start date | 1 February 2018 |
| Primary completion | 28 February 2019 |
| Estimated completion | 18 March 2019 |
| Sites | 1 location across China |
Drugs / interventions tested
- Version BF-1T26 electronic bronchoscope
Conditions studied
- Bronchiectasis Adult — all drugs for Bronchiectasis Adult →
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Who can join
Adults 18 to 80, any sex, with Bronchiectasis Adult. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
No study have evaluated the efficacy and safety of airway clearance therapy (ACT) and bronchoalveolar lavage (BAL) under bronchoscope for bronchiectasis. This study aimed to evaluate the clinical efficacy and safety of tran-bronchoscopy airway clearance and bronchoalveolar lavage in the treatment of moderate to severe bronchiectasis with acute exacerbation:A randomized, prospective cohort study.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Bronchoscopic airway clearance therapy for acute exacerbations of bronchiectasis.
Liu Y, Lu HW, Gu SY, Wang WW, et al · · 2021 · cited 6× · PMID 34537448 · DOI 10.1016/j.ebiom.2021.103587
Verify or expand the search:
- PubMed search for NCT03643302
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bronchiectasis Adult
Currently open trials in the same condition.
- NCT07289100 — Novel Sensors and Artificial Intelligence for Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis and Bronchie · recruiting
- NCT06900062 — The C-BRIDGE Study: China Bronchiectasis Research Involving Databases, Genomics, and Endotyping · recruiting
- NCT06820918 — Physiotherapy With Positive Expiratory Pressure (PEP) Bottle in Patients With Bronchiectasis · NA · active not recruiting
- NCT06801327 — Comparison Between Conventional Respiratory Physiotherapy and the Simeox Device in Patients With Bronchiectasis · NA · recruiting
- NCT06760273 — Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II) · recruiting
Other Shanghai Pulmonary Hospital, Shanghai, China trials
Trials by the same sponsor.
- NCT07469488 — A Clinical Trial on the Outcomes of Comprehensive Enhanced Prophylaxis Management (CEPM) in Chinese Patients With EGFR-M · Phase 4 · not yet recruiting
- NCT07494591 — TEAS for Ipsilateral Shoulder Pain After Video-Assisted Thoracoscopic Lung Surgery · NA · not yet recruiting
- NCT07517640 — Combining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II Trial · Phase 2 · not yet recruiting
- NCT07393438 — Acetohydroxamic Acid Combined With a Short-Course Regimen for MDR-TB (AHA-PLUS) · Phase 2 · not yet recruiting
- NCT07375979 — A Multi-modal Integrating Imaging and Cell-free DNA Methylation in Lung Cancer Early Detection (CMe-Lung): a Multi-cente · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03643302 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai Pulmonary Hospital, Shanghai, China
- Last refreshed: 8 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03643302.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing